Tolerance of an enterally administered simulated amniotic fluid-like solution by neonates recovering from surgery for congenital bowel abnormalities

Journal of Perinatology

Volumn 24, Issue 5, 2004, Pages 295-298

  Lima Rogel, Victoria ^a   Ojeda, Miguel Angel ^a   Villegas, Carolina ^a   Torres Montes, Abraham ^a   Medrano, Silvano ^a   Calhoun, Darlene A ^b   Christensen, Robert D ^b  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTONIC SOLUTION; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SERUM ALBUMIN;

AMNION FLUID; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG TOLERABILITY; ENTERIC FEEDING; FECES ANALYSIS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHESIS; INFANT FEEDING; INTESTINE MALFORMATION; INTESTINE VILLUS; MEDICAL DECISION MAKING; NEWBORN; NEWBORN SURGERY; PEDIATRICIAN; PHASE 1 CLINICAL TRIAL; PILOT STUDY; POSTOPERATIVE CARE; RASH; STOMACH CONTENT; SURGEON; VOMITING;

DRUG COMBINATIONS; ENTERAL NUTRITION; EPOETIN ALFA; ESOPHAGEAL ATRESIA; FILGRASTIM; GASTROSCHISIS; HEMATINICS; HERNIA, UMBILICAL; HUMANS; INFANT, NEWBORN; INTESTINES; PILOT PROJECTS;

EID: 2542463056     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211080     Document Type: Article

References (15)

1. Flake AF, Rychman RC. Selected anomalies and intestinal obstruction. In Fanaroff AA, Martin RJ, editors, Neonatal-Perinatal Medicine, Diseases of the Fetus and Infant. 5th edn, St Louis: Mosby Year Book; 1992. p. 1038-62.
2. Condino AA, Barleycorn AA, Lu W, Waheshwari A, Christensen RD, Calhoun DA. Abnormal intestinal histology in neonates with congenital anomalies of the gastrointestinal tract. Biol Neonate 2004;85(3):145-50.
3. Hirai C, Ichiba H, Saito M, Shintaku H, Yamano T, Kusuda S. Trophic effect of multiple growth factors in amniotic fluid or human milk on cultured human fetal small intestinal cells. J Pediatr Gastroenterol Nutr 2002;32(5):524-8.
4. Calhoun DA. Enteral administration of hematopoietic growth factors in the neonatal intensive care unit. Acta Paediatr Suppl 2002;91(438):43-53.
5. Sullivan SE, Calhoun DA, Maheshwari A, et al. Tolerance of simulated amniotic fluid in premature neonates. Ann Pharmacother 2002;36(10):1518-24.
6. Lima-Rogel V, Calhoun DA, Maheshwari A, et al. Tolerance of a sterile isotonic electrolyte solution containing select recombinant growth factors in neonates recovering from necrotizing enterocolitis. J Perinatol 2003;23(3)200-4.
7. Calhoun DA, Juul SE, McBryde EV, Veerman MW, Christensen RD. Stability of filgrastim and epoetin alfa in a system designed for enteral administration in neonates. Ann Pharmacother. 2000;34(11):1257-61.
8. Calhoun DA Richards BE, Gersting JA, Sullivan SE,Christensen RD. G-CSF and Epo stability in amniotic fluid during simulated in vitro digestion conditions. J Pharm Technol 2002;18:310-15.
9. Calhoun DA, Christensen RD. Human developmental biology of granulocyte colony-stimulating factor. Clin Perinatol 2002;27(3):559-76.
10. Calhoun DA, Maheshwari A, Christensen RD. Recombinant granulocyte colony-stimulating factor administered enterally to neonates is not absorbed.Pediatrics 2003;112(2):421-3.
11. Juul SE, Christensen RD. Absorption of enteral recombinant human erythropoietin by neonates. Ann Pharmacother 2003;37(6)782-6.
12. Mulvihill SJ, Stone MM, Fonkalsrud EW, Debas HT. Trophic effect of amniotic fluid on fetal gastrointestinal development. J Surg Res 1986;40(4):291-6.
13. Hernandez G, Velasco N, Wainstein C, et al. Gut mucosal atrophy after a short enteral fasting period in critically ill patients. J Crit Care 1999;14: 73-7.
14. Ehrenkranz RA, Younes N, Lemons JA, et al. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics 1999;104:280-9.
15. Clark RH, Wagner CL, Merrit RJ, et al. Nutrition in the neonatal intensive care unit: how do we reduce the incidence of extrauterine growth restriction? J Perinatol 2003;23:337-4.